Who We Are

The Clinical and Translational Science Institute (CTSI) is a partnership between New York University (NYU), the NYU Langone Medical Center (NYULMC),  the New York City Health + Hospitals (H+H) and the Nathan Kline Institute that has been designed to transform the way that research is carried out in order to enhance the quality, efficiency, and most importantly, the impact of the research effort at NYU, the Medical Center, H+H, and across the nation as part of the NIH/NCATS CTSA consortium.

The CTSI was established as a result of a Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH).

Our Mission Statement

The CTSI promotes collaborative, interdisciplinary research and training to advance the efficient and safe translation of scientific discoveries from bench to bedside to community.

Our Aims

1) Catalyze and support innovative, collaborative translational research that improves health across the lifespan in our diverse communities.
2) Ensure the quality, safety, and efficiency of local clinical and translational research and to disseminate successful approaches.
3) Stimulate, support, and disseminate innovative methods in the clinical and translational sciences.
4) Foster community-engaged collaborative and team-based science among our diverse community of investigators and stakeholders, rich array of partner institutions, and the national CTSA network.
5) Educate, train, and cultivate the next generation of the translational research workforce.
6) Integrate our clinical, education, and research missions and operations to foster a learning healthcare system.

Our Local Partners

Achieving these aims is only possible through full participation of and collaboration with our partners. To view the complete list of CTSI partners, please click here.

Our National Partner:  The CTSA Program

The Clinical and Translational Science Award program is a key foundation of the NCATS’ efforts to transform the translational science process so that new treatments and cures for disease can be delivered to patients.  Current CTSA initiatives have been designed with carefully considered input about the CTSA program from the Institute of Medicine, a working group of the NCATS Advisory Council, CTSA investigators, patient groups, other NIH Institutes and Centers, biotechnology and pharmaceutical development organizations, regulatory agencies, and the broader clinical and translational research community.  Under NCATS leadership, the program currently supports a national consortium of more than 60 medical research institutions that work together to transform the research process and tackle common problems that no one organization can overcome alone. Ultimately, the CTSA program seeks to accelerate laboratory discoveries into new treatments for patients, train the next generation of clinical and translational researchers, and engage communities in clinical research efforts.